Drug Regulatory Authority of Pakistan (DRAP) and World Health Organization have agreed to boost the mutual cooperation between two organizations. This decision was taken on 20 February 2018 in a meeting between Dr Sheikh Akhter Hussain CEO, DRAP and Dr. Muhammad Assai, WHO Representative for Pakistan. The WHO Rep. recognized that both organizations have a number of common interests. CEO DRAP thanked the WHO for its continued support in the past. WHO and DRAP wish to work together more closely to better serve the people of Pakistan with the common goal of improving the health and provision of safe, quality and efficacious medicines. Both sides discussed matters of mutual interest including effective implementation of DRAP Act, 2012 and issues regarding availability of therapeutic goods. WHO Rep. assured DRAP that his organization will work alongside by DRAP and increase its cooperation for improvement in quality of medicines. He also appreciated the commitment shown by DRAP in performing its duties for betterment of ailing masses. WHO pledges its support to DRAP for enhancement of capacity building, stream lining process of collaborative registration with other WHO member countries and accreditation of DRAP as National Regulatory Authority (NRA). DRAP and WHO mutually agreed on the exchange of information, knowledge, education and training with the shared objective of achieving universal health. ***** ?
PREVIOUS NEXT
